BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 18, 2007
View Archived Issues
Studies Shine Light, Literally, On Neural Substrates Of Sleep
Read More
Cubist Gets Option To Acquire Illumigen; Funds HCV Drug
Cubist Pharmaceuticals Inc. moved to expand its pipeline beyond Cubicin (daptomycin for injection) by picking up an exclusive option to acquire Illumigen Biosciences Inc. (BioWorld Today)
Read More
Pharmion's Amrubicin Begins Pivotal Trial In SCLC Patients
Read More
Osiris Targets GVHD, Crohn's With Stem Cell Therapy
Read More
Other News To Note
Read More
Financings Roundup
Read More
Clinic Roundup
Read More